HealthyBlue Advantage
Alaina Dempsey, LMFT
Marriage & Family Therapy*
Age 32
Be the first to review this provider!
Offers telehealth
Alaina Dempsey, LMFT
Be the first to review this provider!
Reading, MA
Accepting new patients
Offers telehealth
Clinical Overview
Alaina Dempsey, LMFT works in Reading, MA as
Offers Telehealth
This provider offers telehealth appointments. Call the office to schedule.
COMPARE OTHER TOP Family and Marriage Counselors
Contrast Alaina Dempsey with other nearby specialists.
Esther Han, LMFT
Learn More
Tasha Valentino, MFT
Learn More
Razaria Best, LCMFT
Learn More
Amelia Peck, LMFT
Learn More
Kendra Quinton, LCPC
Learn More
Janet Potter, LMFT
Learn More
These providers are on the medical staff of Talkspace.
Advertisement
Insurance & Payment Information
* Please verify this information when scheduling an appointment.
-
-
Choice Plus
-
Harvard Pilgrim Health Care PPO
-
Pathway-CO
-
Complete
-
Open ChoiceSelectAetnaAPCN Choice POS IIManaged Choice (Open Access)Whole Health Colorado Front RangeAPCN Open Access Aetna SelectPremier Care Network Plus - Innovation Health
-
BlueCard Traditional
-
Anthem Blue Cross Blue Shield
Office Locations
-
Reading Pediatrics Associates36 Woburn St, Reading, MA 01867
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Alaina Dempsey?
Step 1 of 3
Your review of Alaina Dempsey, LMFT
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Specialties*
Marriage & Family Therapy
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Alaina Dempsey, LMFT accepts new patients on Medical News Today.
Alaina Dempsey accepts telehealth appointments. Please call Alaina Dempsey's office to make an appointment.
Alaina Dempsey accepts CareFirst Blue Cross Blue Shield, UnitedHealthCare, Harvard Pilgrim Health Care, Anthem, Liberty HealthShare, Aetna, Blue Cross Blue Shield and Anthem Blue Cross Blue Shield as well as many others. See all of the insurances Alaina Dempsey accepts here.
Alaina Dempsey's office is located at 36 Woburn St Reading, MA 01867. Get a map and directions to Alaina Dempsey's office here.
Alaina Dempsey does not have any reviews yet.
Claim Your Profile
Are you Alaina Dempsey, LMFT?
Telehealth Options
This provider has not specified a telehealth appointment method. Would you still like to make an appointment with Alaina Dempsey?
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
The FDA has approved Moderna's new mRNA flu vaccine for adults ages 50 years and older. Moderna expects the vaccine to be available in the United States for the 2026 to 2027 flu season.
A natural compound derived from plant foods containing a certain type of polyphenol may help improve heart function in people with heart failure, a study in animals and human tissue models has found.
Moderna and Merck's neoantigen treatment, combining a personalized mRNA cancer vaccine with the immunotherapy drug pembrolizumab significantly reduced the risk of melanoma recurrence in a phase 3 trial.
